Mesoblast Limited (MEOBF)
Mesoblast Limited, engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
$1.70+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+12.6%
The outlook
Mesoblast Limited currently reads as leaning bullish based on above its 50- & 200-day averages, 28% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range28% of the way from its 52-week low to high
Market cap
$2.20B
52-wk high
$2.59
52-wk low
$1.35
50-day avg
$1.63
200-day avg
$1.60
Trailing P/E
—